Keywords: fda, post-marketing, surveillance, funding, food, drug, administration

FDA Post-Marketing Surveillance Funding

Article | 11 November 1997

The US Food and Drug Administration has no system in place to dealuniformly with adverse event reporting and related matters, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in